Public Calendar: December 30, 2018 - January 5, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., (Acting), Deputy Director for Operations, CDER
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank, Yiannas, Deputy Commissioner for Food Policy & Response
No Significant Event
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Keagan Lenihan, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
Event Date: 01/03/2019
Location: Silver Spring, MD
Subject: User Fees for Approved New Drug Application
FDA Participant/Group: ELIZABETH DICKINSON; PETER CHEN; SUNGJOON CHI; KATHY SCHREIER; AMANDA EDMONDS; THEODORE LIAZOS; TIMOTHY JETTON; KATE GREENWOOD; ANN OXENHAM; SARA BEARDSLEY; JENNIFER FORDE; DONAL PARKS;
Non FDA Participant/Group: Kimberly Leaman , Mark P. Guerrera, Sean Griffin (Sidley Austin LLP); Patrick Witham, Travis Sydow (Paragon BioTeck, Inc.);